Key facts
- Notable investors include Xuhui Hi-Tech.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Shieldbio
- ·The full record, as it builds
Funding rounds
No funding rounds for Shieldbio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shieldbio
Provider of diagnostic technology services intended for clinical and research purposes. The company offers integrated reagents, instruments, and data services enabling healthcare and scientific research markets to achieve disease signal detection, immune profiling, therapy monitoring, and improved diagnostic precision through scalable approaches.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2024
- Website
- shieldbio.cn/
- Ownership
- Privately Held (backing)
Shieldbio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shieldbio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shieldbio in its N-PORT filings yet. We sweep new filings monthly.